Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

160.72
Delayed Data
As of Feb 16
 -0.22 / -0.14%
Today’s Change
84.39
Today|||52-Week Range
174.96
+7.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues714.7M544.1M578.2M651.6M
 
 
 
 
 
Cost of Goods Sold32.1M56.3M57.6M67.6M
 
 
 
 
 
Depreciation And Amortization14.9M14.9M15.2M16.4M
 
 
 
 
 
 
Operating ExpensesGross Income667.7M472.9M505.3M567.6M
 
 
 
 
 
General Expenses386.9M416.7M570.6M441.5M
 
 
 
 
 
Research And Development273.6M289.5M454.9M306.7M
 
 
 
 
 
Total Operating Expenses433.9M487.9M643.4M525.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income280.8M56.2M-65.3M126.1M
 
 
 
 
 
Extraordinary Charge-10.0M-3.5M-264.9M-1.5M
 
 
 
 
 
Interest Expense On Debt16.8M14.7M13.6M12.5M
 
 
 
 
 
Other Expenses-544.0K-2.5M-73.5M352.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income253.5M35.5M-417.2M112.4M
 
 
 
 
 
Income Taxes-4.0M-4.3M-125.9M-10.3M
 
 
 
 
 
Minority Interest-1.8M-13.2M-188.3M-1.5M
 
 
 
 
 
Net Income247.4M18.0M-103.0M100.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS246.0M247.5M250.3M251.6M
 
 
 
 
 
Shares To Calculate EPS Diluted248.7M251.6M250.3M256.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.99$0.07-$0.41$0.39
 
 
 
 
 
EPS Diluted$0.99$0.07-$0.41$0.39